Choline kinase inhibitory effect and antiproliferative activity of new 1,1′,1″-(benzene-1,3,5-triylmethylene)tris?4-[(disubstituted)amino]pyridinium? tribromides
摘要:
Four derivatives of 1,1'-(benzene-1,3-diylmethylene)bis{4-[(disubstituted)amino]-pyridinium} dibromides (2-5) and six derivatives of 1, 1', 1"-(benzene-1,3,5-triylmethylene)-tris{4-[(disubstituted)amino]pyridinium} tribromides (6-11) were synthesised and examined for their inhibition of human choline kinase (ChoK) and antiproliferative activities. The latter are more potent as ChoK inhibitors than the former, but the antiproliferative activities against the HT-29 cell line show the opposite tendency. The higher affinity of the trispyridinium compared with the bispyridinium ones may be due to direct binding of the third pyridinium group to ChoK or may arise from a reduction of the unfavourable entropy of binding via an increase of the 'local concentration' of pyridinium groups. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
Choline kinase inhibitory effect and antiproliferative activity of new 1,1′,1″-(benzene-1,3,5-triylmethylene)tris?4-[(disubstituted)amino]pyridinium? tribromides
作者:A Conejo-García
DOI:10.1016/s0223-5234(02)00004-1
日期:2003.1
Four derivatives of 1,1'-(benzene-1,3-diylmethylene)bis4-[(disubstituted)amino]-pyridinium} dibromides (2-5) and six derivatives of 1, 1', 1"-(benzene-1,3,5-triylmethylene)-tris4-[(disubstituted)amino]pyridinium} tribromides (6-11) were synthesised and examined for their inhibition of human choline kinase (ChoK) and antiproliferative activities. The latter are more potent as ChoK inhibitors than the former, but the antiproliferative activities against the HT-29 cell line show the opposite tendency. The higher affinity of the trispyridinium compared with the bispyridinium ones may be due to direct binding of the third pyridinium group to ChoK or may arise from a reduction of the unfavourable entropy of binding via an increase of the 'local concentration' of pyridinium groups. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.